APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Discovery AI Tools

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Drug Discovery AI Tools Market Outlook and Growth Opportunities 2026

12 August 2026196 pages

Choose your research edition.

Industry ResearchDrug Discovery AI Tools Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Discovery AI Tools Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Drug Discovery AI Tools Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Discovery AI Tools Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Discovery AI Tools Market Analysis and Forecast 2026-2032170 pages · $4,950 USD

Market perspective

The global Drug Discovery AI Tools market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Drug Discovery AI Tools is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drug Discovery AI Tools is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug Discovery AI Tools is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Drug Discovery AI Tools market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Drug Discovery AI Tools market include Exscientia, Insilico Medicine, Valo Health, Owkin, XtalPi, Healx, Atomwise, BenevolentAI and Recursion, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Drug Discovery AI Tools market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drug Discovery AI Tools and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drug Discovery AI Tools revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Drug Discovery AI Tools market.

Drug Discovery AI Tools Segment by Company

Exscientia

Insilico Medicine

Valo Health

Owkin

XtalPi

Healx

Atomwise

BenevolentAI

Recursion

Drug Discovery AI Tools Segment by Type

Drug Target Identification

Compound Screening

Efficacy Prediction

Clinical Trial Optimization

Drug Discovery AI Tools Segment by Application

Contract Research Organizations

Research Centers and Academic Institutes

Pharmaceutical and Biotechnology Companies

Drug Discovery AI Tools Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Drug Discovery AI Tools status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Drug Discovery AI Tools key companies, revenue, market share, and recent developments.

3. To split the Drug Discovery AI Tools breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Drug Discovery AI Tools market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Drug Discovery AI Tools significant trends, drivers, influence factors in global and regions.

6. To analyze Drug Discovery AI Tools competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Discovery AI Tools market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Discovery AI Tools and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Discovery AI Tools.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drug Discovery AI Tools industry.

Chapter 3: Detailed analysis of Drug Discovery AI Tools company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Drug Discovery AI Tools in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Drug Discovery AI Tools in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Drug Discovery AI Tools Industry Trends Table 2. Drug Discovery AI Tools Industry Drivers Table 3. Drug Discovery AI Tools Industry Opportunities and Challenges Table 4. Drug Discovery AI Tools Industry Restraints Table 5. Global Drug Discovery AI Tools Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Drug Discovery AI Tools Revenue Share by Company (2021-2026) Table 7. Global Drug Discovery AI Tools Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Drug Discovery AI Tools Key Company Manufacturing Base & Headquarters Table 9. Global Drug Discovery AI Tools Company, Product Type & Application Table 10. Global Drug Discovery AI Tools Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Drug Discovery AI Tools by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Drug Target Identification Table 15. Significant Companies of Compound Screening Table 16. Significant Companies of Efficacy Prediction Table 17. Significant Companies of Clinical Trial Optimization Table 18. Global Drug Discovery AI Tools Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Drug Discovery AI Tools Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Drug Discovery AI Tools Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Drug Discovery AI Tools Sales Value Share by Type (2021-2026) Table 22. Global Drug Discovery AI Tools Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Contract Research Organizations Table 24. Significant Companies of Research Centers and Academic Institutes Table 25. Significant Companies of Pharmaceutical and Biotechnology Companies Table 26. Global Drug Discovery AI Tools Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Drug Discovery AI Tools Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Drug Discovery AI Tools Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Drug Discovery AI Tools Sales Value Share by Application (2021-2026) Table 30. Global Drug Discovery AI Tools Sales Value Share by Application (2027-2032) Table 31. Global Drug Discovery AI Tools Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Drug Discovery AI Tools Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Drug Discovery AI Tools Sales Value Share by Region (2021-2026) Table 34. Global Drug Discovery AI Tools Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Drug Discovery AI Tools Sales Value Share by Region (2027-2032) Table 36. Global Drug Discovery AI Tools Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Drug Discovery AI Tools Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Drug Discovery AI Tools Sales Value Market Share by Country (2021-2026) Table 39. Global Drug Discovery AI Tools Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Drug Discovery AI Tools Sales Value Market Share by Country (2027-2032) Table 41. Exscientia Company Information Table 42. Exscientia Business Overview Table 43. Exscientia Drug Discovery AI Tools Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Exscientia Drug Discovery AI Tools Product Portfolio Table 45. Exscientia Recent Development Table 46. Insilico Medicine Company Information Table 47. Insilico Medicine Business Overview Table 48. Insilico Medicine Drug Discovery AI Tools Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Insilico Medicine Drug Discovery AI Tools Product Portfolio Table 50. Insilico Medicine Recent Development Table 51. Valo Health Company Information Table 52. Valo Health Business Overview Table 53. Valo Health Drug Discovery AI Tools Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Valo Health Drug Discovery AI Tools Product Portfolio Table 55. Valo Health Recent Development Table 56. Owkin Company Information Table 57. Owkin Business Overview Table 58. Owkin Drug Discovery AI Tools Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Owkin Drug Discovery AI Tools Product Portfolio Table 60. Owkin Recent Development Table 61. XtalPi Company Information Table 62. XtalPi Business Overview Table 63. XtalPi Drug Discovery AI Tools Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. XtalPi Drug Discovery AI Tools Product Portfolio Table 65. XtalPi Recent Development Table 66. Healx Company Information Table 67. Healx Business Overview Table 68. Healx Drug Discovery AI Tools Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Healx Drug Discovery AI Tools Product Portfolio Table 70. Healx Recent Development Table 71. Atomwise Company Information Table 72. Atomwise Business Overview Table 73. Atomwise Drug Discovery AI Tools Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Atomwise Drug Discovery AI Tools Product Portfolio Table 75. Atomwise Recent Development Table 76. BenevolentAI Company Information Table 77. BenevolentAI Business Overview Table 78. BenevolentAI Drug Discovery AI Tools Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. BenevolentAI Drug Discovery AI Tools Product Portfolio Table 80. BenevolentAI Recent Development Table 81. Recursion Company Information Table 82. Recursion Business Overview Table 83. Recursion Drug Discovery AI Tools Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Recursion Drug Discovery AI Tools Product Portfolio Table 85. Recursion Recent Development Table 86. Research Programs/Design for This Report Table 87. Authors List of This Report Table 88. Secondary Sources Table 89. Primary Sources List of Figures Figure 1. Drug Discovery AI Tools Product Image Figure 2. Global Drug Discovery AI Tools Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Discovery AI Tools Market Size (2021-2032) & (US$ Million) Figure 4. Global Drug Discovery AI Tools Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Drug Target Identification Image Figure 8. Compound Screening Image Figure 9. Efficacy Prediction Image Figure 10. Clinical Trial Optimization Image Figure 11. Global Drug Discovery AI Tools Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Drug Discovery AI Tools Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Drug Discovery AI Tools Sales Value Share by Type (2021-2032) Figure 14. Contract Research Organizations Image Figure 15. Research Centers and Academic Institutes Image Figure 16. Pharmaceutical and Biotechnology Companies Image Figure 17. Global Drug Discovery AI Tools Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Drug Discovery AI Tools Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Drug Discovery AI Tools Sales Value Share by Application (2021-2032) Figure 20. Global Drug Discovery AI Tools Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Drug Discovery AI Tools Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Drug Discovery AI Tools Sales Value (2021-2032) & (US$ Million) Figure 23. North America Drug Discovery AI Tools Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Drug Discovery AI Tools Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Drug Discovery AI Tools Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Drug Discovery AI Tools Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Drug Discovery AI Tools Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Drug Discovery AI Tools Sales Value (2021-2032) & (US$ Million) Figure 29. South America Drug Discovery AI Tools Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Drug Discovery AI Tools Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Drug Discovery AI Tools Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Drug Discovery AI Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Drug Target Identification
  • Compound Screening
  • Efficacy Prediction
  • Clinical Trial Optimization
Applications
  • Contract Research Organizations
  • Research Centers and Academic Institutes
  • Pharmaceutical and Biotechnology Companies
Companies covered
  • Exscientia
  • Insilico Medicine
  • Valo Health
  • Owkin
  • XtalPi
  • Healx
  • Atomwise
  • BenevolentAI
  • Recursion

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Drug Discovery AI Tools Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Drug Discovery AI Tools Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Drug Discovery AI Tools Market Dynamics
  1. 2.1 Drug Discovery AI Tools Industry Trends
  2. 2.2 Drug Discovery AI Tools Industry Drivers
  3. 2.3 Drug Discovery AI Tools Industry Opportunities and Challenges
  4. 2.4 Drug Discovery AI Tools Industry Restraints
3 Drug Discovery AI Tools Market by Company
  1. 3.1 Global Drug Discovery AI Tools Company Revenue Ranking in 2025
  2. 3.2 Global Drug Discovery AI Tools Revenue by Company (2021-2026)
  3. 3.3 Global Drug Discovery AI Tools Company Ranking (2024-2026)
  4. 3.4 Global Drug Discovery AI Tools Company Manufacturing Base and Headquarters
  5. 3.5 Global Drug Discovery AI Tools Company Product Type and Application
  6. 3.6 Global Drug Discovery AI Tools Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Drug Discovery AI Tools Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Drug Discovery AI Tools Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Drug Discovery AI Tools Market by Type
  1. 4.1 Drug Discovery AI Tools Type Introduction
  2. 4.1.1 Drug Target Identification
  3. 4.1.2 Compound Screening
  4. 4.1.3 Efficacy Prediction
  5. 4.1.4 Clinical Trial Optimization
  6. 4.2 Global Drug Discovery AI Tools Sales Value by Type
  7. 4.2.1 Global Drug Discovery AI Tools Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Drug Discovery AI Tools Sales Value by Type (2021-2032)
  9. 4.2.3 Global Drug Discovery AI Tools Sales Value Share by Type (2021-2032)
5 Drug Discovery AI Tools Market by Application
  1. 5.1 Drug Discovery AI Tools Application Introduction
  2. 5.1.1 Contract Research Organizations
  3. 5.1.2 Research Centers and Academic Institutes
  4. 5.1.3 Pharmaceutical and Biotechnology Companies
  5. 5.2 Global Drug Discovery AI Tools Sales Value by Application
  6. 5.2.1 Global Drug Discovery AI Tools Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Drug Discovery AI Tools Sales Value by Application (2021-2032)
  8. 5.2.3 Global Drug Discovery AI Tools Sales Value Share by Application (2021-2032)
6 Drug Discovery AI Tools Regional Value Analysis
  1. 6.1 Global Drug Discovery AI Tools Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drug Discovery AI Tools Sales Value by Region (2021-2032)
  3. 6.2.1 Global Drug Discovery AI Tools Sales Value by Region: 2021-2026
  4. 6.2.2 Global Drug Discovery AI Tools Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Drug Discovery AI Tools Sales Value (2021-2032)
  7. 6.3.2 North America Drug Discovery AI Tools Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Drug Discovery AI Tools Sales Value (2021-2032)
  10. 6.4.2 Europe Drug Discovery AI Tools Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Drug Discovery AI Tools Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Drug Discovery AI Tools Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Drug Discovery AI Tools Sales Value (2021-2032)
  16. 6.6.2 South America Drug Discovery AI Tools Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Drug Discovery AI Tools Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Drug Discovery AI Tools Sales Value Share by Country, 2025 VS 2032
7 Drug Discovery AI Tools Country-level Value Analysis
  1. 7.1 Global Drug Discovery AI Tools Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Drug Discovery AI Tools Sales Value by Country (2021-2032)
  3. 7.2.1 Global Drug Discovery AI Tools Sales Value by Country (2021-2026)
  4. 7.2.2 Global Drug Discovery AI Tools Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Drug Discovery AI Tools Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Drug Discovery AI Tools Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Drug Discovery AI Tools Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Exscientia
  2. 8.1.1 Exscientia Company Information
  3. 8.1.2 Exscientia Business Overview
  4. 8.1.3 Exscientia Drug Discovery AI Tools Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Exscientia Drug Discovery AI Tools Product Portfolio
  6. 8.1.5 Exscientia Recent Developments
  7. 8.2 Insilico Medicine
  8. 8.2.1 Insilico Medicine Company Information
  9. 8.2.2 Insilico Medicine Business Overview
  10. 8.2.3 Insilico Medicine Drug Discovery AI Tools Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Insilico Medicine Drug Discovery AI Tools Product Portfolio
  12. 8.2.5 Insilico Medicine Recent Developments
  13. 8.3 Valo Health
  14. 8.3.1 Valo Health Company Information
  15. 8.3.2 Valo Health Business Overview
  16. 8.3.3 Valo Health Drug Discovery AI Tools Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Valo Health Drug Discovery AI Tools Product Portfolio
  18. 8.3.5 Valo Health Recent Developments
  19. 8.4 Owkin
  20. 8.4.1 Owkin Company Information
  21. 8.4.2 Owkin Business Overview
  22. 8.4.3 Owkin Drug Discovery AI Tools Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Owkin Drug Discovery AI Tools Product Portfolio
  24. 8.4.5 Owkin Recent Developments
  25. 8.5 XtalPi
  26. 8.5.1 XtalPi Company Information
  27. 8.5.2 XtalPi Business Overview
  28. 8.5.3 XtalPi Drug Discovery AI Tools Revenue and Gross Margin (2021-2026)
  29. 8.5.4 XtalPi Drug Discovery AI Tools Product Portfolio
  30. 8.5.5 XtalPi Recent Developments
  31. 8.6 Healx
  32. 8.6.1 Healx Company Information
  33. 8.6.2 Healx Business Overview
  34. 8.6.3 Healx Drug Discovery AI Tools Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Healx Drug Discovery AI Tools Product Portfolio
  36. 8.6.5 Healx Recent Developments
  37. 8.7 Atomwise
  38. 8.7.1 Atomwise Company Information
  39. 8.7.2 Atomwise Business Overview
  40. 8.7.3 Atomwise Drug Discovery AI Tools Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Atomwise Drug Discovery AI Tools Product Portfolio
  42. 8.7.5 Atomwise Recent Developments
  43. 8.8 BenevolentAI
  44. 8.8.1 BenevolentAI Company Information
  45. 8.8.2 BenevolentAI Business Overview
  46. 8.8.3 BenevolentAI Drug Discovery AI Tools Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BenevolentAI Drug Discovery AI Tools Product Portfolio
  48. 8.8.5 BenevolentAI Recent Developments
  49. 8.9 Recursion
  50. 8.9.1 Recursion Company Information
  51. 8.9.2 Recursion Business Overview
  52. 8.9.3 Recursion Drug Discovery AI Tools Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Recursion Drug Discovery AI Tools Product Portfolio
  54. 8.9.5 Recursion Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst